| Financial Year |
March 31 2023 |
| Monetary Funds |
715,115,006.57 |
| Held-for-trading Financial Assets |
93,393,506.41 |
| Notes Receivable |
254,695,241.38 |
| Accounts Receivable |
391,591,904.65 |
| Advances to Suppliers |
16,365,960.40 |
| Other Receivables |
24,845,458.47 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
21,490,933.02 |
| Dividend Receivable |
-- |
| Inventories |
156,642,293.28 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
5,536,014.57 |
| Total Current Assets |
1,658,185,385.73 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
8,413,013.70 |
| Investment Properties |
-- |
| Fixed Assetes |
291,492,599.16 |
| Under-construction Projects |
9,979,632.46 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
43,456,806.45 |
| R&D expenses |
-- |
| Goodwill |
9,040,438.75 |
| Long-Term Deferred and Prepaid Expenses |
295,183.19 |
| Deferred Income Tax Assets |
18,382,364.57 |
| Other Non-Current Assets |
1,092,966,640.00 |
| Sub-Total of Non-Current Assets |
3,099,451,810.76 |
| Total Assets |
4,757,637,196.49 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
159,766,291.98 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
960,670.63 |
| Taxes Payable |
30,611,854.67 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
170,058,075.23 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
7,305,923.58 |
| Sub-Total of Current Liabilities |
393,629,545.77 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
211,071,801.76 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
249,150,348.13 |
| Total Liabilities |
642,779,893.90 |
| Paid-In Capital(Or Share Stock) |
1,046,000,000.00 |
| Capital Surplus |
8,624,500.00 |
| Surplus Reserve |
217,394,610.15 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,647,934,128.00 |
| Minority Stockholder's Interest |
-782,783.92 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,115,640,086.51 |
| Owner's Equity（Stockholder's Equity） |
4,114,857,302.59 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,757,637,196.49 |
